Rik Oldenkamp

Rik Oldenkamp

Auto-generated profile, based on publicly available information

Rik Oldenkamp

Amsterdam Institute for Life and Environment (A-LIFE) - Section Chemistry for Environment and Health, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, 1081 HZ, the Netherlands

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
John WilkinsonJohn Wilkinson
John Wilkinson
ABAlistair B. A. Boxall
Alistair B. A. Boxall
DKDana W. Kolpin
Dana W. Kolpin
KLKenneth M. Y. Leung
Kenneth M. Y. Leung
RLRacliffe W. S. Lai
Racliffe W. S. Lai
Charles TetaCharles Teta
Charles Teta
Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. While numerous studies have monitored APIs in rivers, these employ different analytical methods, measure different APIs, and have ignored many of the countries of the world. This makes it difficult to quantify the scale of the problem from a global perspective. Furthermore, comparison of the existing data, generated for different studies/regions/continents, is challenging due to the vast differences between the analytical methodologies employed. Here, we present a global-scale study of API pollution in 258 of the world’s rivers, representing the environmental influence of 471.4 million people across 137 geographic regions. Samples were obtained from 1,052 locations in 104 countries (representing all continents and 36 countries not previously studied for API contamination) and analyzed for 61 APIs. Highest cumulative API concentrations were observed in sub-Saharan Africa, south Asia, and South America. The most contaminated sites were in low- to middle-income countries and were associated with areas with poor wastewater and waste management infrastructure and pharmaceutical manufacturing. The most frequently detected APIs were carbamazepine, metformin, and caffeine (a compound also arising from lifestyle use), which were detected at over half of the sites monitored. Concentrations of at least one API at 25.7% of the sampling sites were greater than concentrations considered safe for aquatic organisms, or which are of concern in terms of selection for antimicrobial resistance. Therefore, pharmaceutical pollution poses a global threat to environmental and human health, as well as to delivery of the United Nations Sustainable Development Goals.

27 September 2013 in Environmental Science & Technology
Verified
Journal Article
Closed access
AJAndrew C. Johnson
Andrew C. Johnson
EDEgon Dumont
Egon Dumont
RWRichard J. Williams
Richard J. Williams
RORik Oldenkamp
Rik Oldenkamp
ICIwona Cisowska
Iwona Cisowska
JSJohn P. Sumpter
John P. Sumpter

1 May 2016 in Environmental Pollution
Verified
Journal Article
Closed access
RORik Oldenkamp
Rik Oldenkamp
RZRosalie van Zelm
Rosalie van Zelm
MHMark Huijbregts
Mark Huijbregts

10 October 2018 in Environmental Science & Technology
Verified
Journal Article
Open access
RORik Oldenkamp
Rik Oldenkamp
SHSelwyn Hoeks
Selwyn Hoeks
MČMirza Čengić
Mirza Čengić
VBValerio Barbarossa
Valerio Barbarossa
EBEmily E. Burns
Emily E. Burns
ARAd M. J. Ragas
Ad M. J. Ragas
Environmental risk assessment of pharmaceuticals requires the determination of their environmental exposure concentrations. Existing exposure modelling approaches are often computationally demanding, require extensive data collection and processing efforts, have a limited spatial resolution, and have undergone limited evaluation against monitoring data. Here, we present ePiE (exposure to Pharmaceuticals in the Environment), a spatially explicit model calculating concentrations of active pharmaceutical ingredients (APIs) in surface waters across Europe at ~1 km resolution. ePiE strikes a balance between generating data on exposure at high spatial resolution while having limited computational and data requirements. Comparison of model predictions with measured concentrations of a diverse set of 35 APIs in the river Ouse (UK) and Rhine basins (North West Europe), showed around 95% were within an order of magnitude. Improved predictions were obtained for the river Ouse basin (95% within a factor of 6; 55% within a factor of 2), where reliable consumption data were available and the monitoring study design was coherent with the model outputs. Application of ePiE in a prioritisation exercise for the Ouse basin, identified metformin, gabapentin, and acetaminophen as priority when based on predicted exposure concentrations. After incorporation of toxic potency, this changed to desvenlafaxine, loratadine and hydrocodone.

1 July 2011 in Environment International
Verified
Journal Article
Closed access
ARAd M.J. Ragas
Ad M.J. Ragas
ROR. Oldenkamp
R. Oldenkamp
NPN.L. Preeker
N.L. Preeker
JWJ. Wernicke
J. Wernicke
USU. Schlink
U. Schlink

21 February 2019 in Environmental Research Letters
Verified
Journal Article
Open access
PDF file
RORik Oldenkamp
Rik Oldenkamp
ABArthur H W Beusen
Arthur H W Beusen
MHMark Huijbregts
Mark Huijbregts